-
Mashup Score: 0
Die Kontroverse um die Ernennung von Damian Müller zum Präsidenten des Verwaltungsrates der Luks Gruppe hat diesen am Samstag dazu veranlasst, auf das Amt zu verzichten.
Source: www.luzernerzeitung.chCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2No cervical cancer cases in fully HPV-vaccinated women in Scotland - 4 month(s) ago
A study published by Public Health Scotland finds that the HPV vaccine is “highly effective”.
Source: www.bbc.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2No cervical cancer cases in fully HPV-vaccinated women in Scotland - 4 month(s) ago
A study published by Public Health Scotland finds that the HPV vaccine is “highly effective”.
Source: www.bbc.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial - 4 month(s) ago
Leukemia – Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial - 10 month(s) ago
Leukemia – Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0FDA grants accelerated approval to pirtobrutinib - 1 year(s) ago
FDA grants accelerated approval to pirtobrutinib for relapsed or refractory mantle cell lymphoma
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0MEI Pharma and Kyowa Kirin Announce Discontinuation of Zandelisib Development Outside of Japan Following Recent FDA Meeting - 1 year(s) ago
MEI Pharma, Inc. (Nasdaq: MEIP), a pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE:
Source: www.businesswire.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
General Sessions Late-Breaking Abstracts Session Research, clinical trials, adult, Clinical Research, Combination therapy, Diseases, Therapies, therapy sequence, Lymphoid Malignancies, Adverse Events, Study Population, Human Gerald Illerhaus, MD1, Andrés J.M. Ferreri, MD2, Mascha Binder, MD3*, Peter Borchmann4, Justin Hasenkamp, MD5*, Stephan Stilgenbauer, MD6,…
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Regulatory News: Disclaimer: Intended for international media and investor audiences only Ipsen (Euronext: IPN; ADR: IPSEY) announced the Phase III NA
Source: www.businesswire.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Baz Luhrmann - Everybody's Free To Wear Sunscreen - 2 year(s) ago
THIS IS THE ORIGINAL MUSIC VIDEOGreat Music video from the nineties !The lyrics are taken from a famous essay — written in 1997 by Mary Schmich, a columnist …
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet
Anybody talked to Prof Verena Briner? @KantonsspitalLU @mtschuor3 She already lead @Novartis successfully. Time for a woman as VR President. https://t.co/6C8lq2uFlw